ENGOT-EN1/FANDANGO
Study documentation (link to documents is only accessible with password to www.nsgo.org).
Click HERE for access.
Study sponsor | NSGO |
NSGO Project Manager | Mette Engell NSGO, Rigshospitalet, Copenhagen, Denmark +45 3545 3398 |
Study Chair | Mansoor Raza Mirza +45 3545 3939 |
Drug | Nintedanib |
Phase | II |
Randomized trial | Yes |
Type | Double-blinded |
Total number of patients | 148 patients required |
Number of patients recruited | Recruitment statistics – link |
Trial status | Recruitment closed |
Date of first site activated | 16.11.2016 |
eCRF | Open Clinica test – link (protected information – access only with login) Open Clinica Live – link (protected information – access only with login) |
Site list | Site list addes soon (protected information – access only with login) |
Protocol summary | ClinicalTrials.gov – link |
Click HERE for access.